About Us
Who We Are
Boxer Capital Management is a biotechnology investment firm dedicated to fundamental, research-based investing in specialized and precision medicine. For nearly two decades, the senior investment team has been located in the life-science hub of San Diego, California where we have been able to focus on independent research. Our expertise is anchored in the multi-year operational experience and recognition in identifying, funding, and scaling innovation in biotechnology companies. The sector and therapeutic disciplines continue to evolve, and we strongly believe we have built a proven framework to grow with it.
What We Do
Boxer Capital Management looks for value across all stages of the biotechnology ecosystem; from company building and early-stage to late-stage and crossover private investments to public markets. We seek to invest with duration in high quality assets taking a value add approach where the opportunity and risk reward is most compelling.
A key hallmark of our ethos is the continuity of team and unique backgrounds we each bring.
We are guided by our collective values and accomplish our shared mission together.
Our Values
Integrity
- We strive to make investments that have the potential to transform the lives of those who need it most
- We learn from past investments and embrace shared lessons learned
Commitment
- We have an insatiable desire to win and will to grind
- We do not wait for consensus and challenge the status quo
- We focus on overlooked and forgotten areas of the market
Culture
- We are committed to each other’s success
- We are intellectually curious and passionate in the pursuit of continuous improvement
- We embrace humility, honesty, and kindness
Alignment
- We take an investor first approach while being mindful of market structure and liquidity dynamics
- The founders and employees are significant investors in the business
Our Investment Philosophy
Through disciplined analysis, we seek to identify investment opportunities focused on transformative medical advancements in precision medicine. We invest across the drug life cycle responding to changes in the biotechnology ecosystem and investment opportunity set. Through this process, we are continuously refining and adapting our investment research and approach providing an environment for our team to compete and innovate successfully.
Our team includes scientists who have led research and discovery across multiple therapeutic indications for drugs that are treating patients today. Combining this scientific experience with nearly two decades of investment experience has allowed us to structure a repeatable process of bottom-up idea generation with top-down oversight from our founder.
Life Changing Medical Advancements
Invest to unlock better patient care and medicine for all through fundamental, scientific research
Multi-Disciplinary Analysis
Seek investments with a differentiated approach, clear rationale, and the right management team through the following lens:
- Scientific
- Clinical
- Commercial
- Regulatory
Translating Innovation Into Opportunity
Leverage the predictive value of the team’s fundamental due diligence to identify early-stage investments centered around novel, innovative drug targets